(KAP-o-seez sar-KO-ma)
A type of cancer
characterized by the abnormal growth of blood vessels
that develop into skin lesions or occur internally.
|
A drug being studied in
the treatment of cancer. It belongs to a family of drugs
called topoisomerase inhibitors. It is related to the
anticancer drug camptothecin.
|
KPS. A standard way of
measuring the ability of cancer patients to perform
ordinary tasks. The scores range from 0 to 100, with a
higher score indicating a better ability to carry out
daily activities. KPS may be used to determine a
patient's prognosis, to measure changes in functioning,
or to decide if a patient could be included in a
clinical trial.
|
(KEY-loyd)
A thick, irregular scar
caused by excessive tissue growth at the site of an
incision or wound.
|
A glycosaminoglycan (a
type of polysaccharide) found in cartilage and in the
cornea of the eye.
|
A substance that
stimulates the growth of epithelial cells that line the
surface of the mouth and intestinal tract.
|
(KER-a-toe-AK-an-THOW-ma)
A benign (noncancerous),
rapidly growing skin tumor that usually occurs on
sun-exposed areas of the skin and that can go away
without treatment.
|
A drug that treats
infection caused by a fungus. It is also used as a
treatment for prostate cancer because it can block the
production of male sex hormones.
|
A drug that belongs to a
family of drugs called nonsteroidal anti-inflammatory
agents. It is being studied in cancer prevention.
|
KLH. One of a group of
drugs called immune modulators, given as a vaccine to
help the body respond to cancer.
|
(KID-neez)
A pair of organs in the
abdomen that remove waste from the blood (as urine),
produce erythropoietin (a substance that stimulates red
blood cell production), and play a role in blood
pressure regulation.
|
White blood cells that
attack tumor cells and body cells that have been invaded
by foreign substances.
|
A measure of weight. A
kilogram is equal to 2.2 pounds.
|
A bacteria that frequently
causes lung, urinary tract, intestinal, and wound
infections.
|
Karnofsky Performance
Status. A standard way of measuring the ability of
cancer patients to perform ordinary tasks. The scores
range from 0 to 100, with a higher score indicating a
better ability to carry out daily activities. KPS may be
used to determine a patient's prognosis, to measure
changes in functioning, or to decide if a patient could
be included in a clinical trial.
|
An anticancer drug that
belongs to a family of drugs called antitumor
antibiotics. It is an anthracycline.
|
A drug being studied in
the treatment of cancer. It is a biological response
modifier that belongs to the family of drugs called
glycosphingolipids or agelasphins.
|
(KROO-ken-berg TOO-mer)
A tumor in the ovary
caused by the spread of stomach cancer.
|
A semisynthetic anticancer
drug that belongs to the family of drugs called
antitumor antibiotics.
|
